EP2695609
Samsetningar af sýtidín hliðstæðum til inntöku og aðferðir til að nota þær
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
14.5.2009EP published:
11.12.2019EP application number:
13182721.4
EP translation filed:
21.1.2020Grant published:
15.2.2020EPO information:
European Patent Register
Max expiry date:
13.5.2029Expiry date:
13.5.2026
Title:
Oral formulations of cytidine analogs and methods of use thereof
Timeline
Today
14.5.2009EP application
11.12.2019EP Publication
21.1.2020Translation submitted
15.2.2020Registration published
13.5.2026Expires
Owner
Name:
CELGENE CORPORATIONAddress:
Route 206 & Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
Etter, Jeffrey B.Address:
Boulder, CO 80302, US
Name:
Lai, MeiAddress:
Longmont, CO 80504, US
Name:
Backstrom, Jay T.Address:
Leawood, KS 66224, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
53609 PDate:
15.5.2008Country:
US
Number:
201145 PDate:
5.12.2008Country:
US
Number:
157875 PDate:
5.3.2009Country:
US
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 31/7068
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 17.3.2020
Expires: 13.5.2021
Payer: Patice ehf.
Number: 13
Paid: 8.4.2021
Expires: 13.5.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.4.2022
Expires: 13.5.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.4.2023
Expires: 13.5.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.4.2024
Expires: 13.5.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 5.5.2025
Expires: 13.5.2026
Payer: Árnason Faktor ehf.